» Articles » PMID: 15220766

Choice of Primary Anesthetic Regimen Can Influence Intensive Care Unit Length of Stay After Coronary Surgery with Cardiopulmonary Bypass

Overview
Journal Anesthesiology
Specialty Anesthesiology
Date 2004 Jun 29
PMID 15220766
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Volatile anesthetics protect the myocardium during coronary surgery. This study hypothesized that the use of a volatile agent in the anesthetic regimen would be associated with a shorter intensive care unit (ICU) and hospital length of stay (LOS), compared with a total intravenous anesthetic regimen.

Methods: Elective coronary surgery patients were randomly assigned to receive propofol (n = 80), midazolam (n = 80), sevoflurane (n = 80), or desflurane (n = 80) as part of a remifentanil-based anesthetic regimen. Multiple logistic regression analysis was used to identify the independent variables associated with a prolonged ICU LOS.

Results: Patient characteristics were similar in all groups. ICU and hospital LOS were lower in the sevoflurane and desflurane groups (P < 0.01). The number of patients who needed a prolonged ICU stay (> 48 h) was also significantly lower (propofol: n = 31; midazolam: n = 34; sevoflurane: n = 10; desflurane: n = 15; P < 0.01). Occurrence of atrial fibrillation, a postoperative troponin I concentration greater than 4 ng/ml, and the need for prolonged inotropic support (> 12 h) were identified as the significant risk factors for prolonged ICU LOS. Postoperative troponin I concentrations and need for prolonged inotropic support were lower in the sevoflurane and desflurane group (P < 0.01). Postoperative cardiac function was also better preserved with the volatile anesthetics. The incidence of other postoperative complications was similar in all groups.

Conclusions: The use of sevoflurane and desflurane resulted in a shorter ICU and hospital LOS. This seemed to be related to a better preservation of early postoperative myocardial function.

Citing Articles

Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies.

Chiari P, Fellahi J Front Med (Lausanne). 2024; 11:1424188.

PMID: 38962735 PMC: 11220133. DOI: 10.3389/fmed.2024.1424188.


Intra-operative anesthetic induced myocardial protection during cardiothoracic surgery: a literature review.

Abraham A, Elliott C, Abraham M, Ahuja S J Thorac Dis. 2024; 15(12):7042-7049.

PMID: 38249920 PMC: 10797362. DOI: 10.21037/jtd-23-1101.


Influence of Anesthetics on Cardiac Index and Metabolic Outcomes in Mitral and Aortic Valve Replacement in Adults: A Randomized Clinical Study.

Baiterek B, Mustafin A Anesth Pain Med. 2023; 13(2):e134119.

PMID: 37601959 PMC: 10439691. DOI: 10.5812/aapm-134119.


Remimazolam for cardiovascular anesthesia.

Hirata N J Anesth. 2023; 37(6):825-827.

PMID: 37584688 DOI: 10.1007/s00540-023-03242-z.


Sevoflurane Improves Ventricular Conduction by Exosomes Derived from Rat Cardiac Fibroblasts After Hypothermic Global Ischemia-Reperfusion Injury.

Ma Y, Cao Y, Gao H, Tong R, Yi J, Zhang Z Drug Des Devel Ther. 2023; 17:1719-1732.

PMID: 37333963 PMC: 10275581. DOI: 10.2147/DDDT.S408595.